Skip Navigation

Phone Service Update

We are experiencing extremely high call volume related to COVID-19 vaccine interest. Please understand that our phone lines must be clear for people with urgent and acute medical care needs. Unfortunately, this means we are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this web site. Read more COVID-19 Vaccine Information

Patient Care Options | Visitor Guidelines | Coronavirus Information | Self-Checker | Get Email Alerts

Menu Search

Sidney Kimmel Cancer Center / Centers & Clinics


In This Section      

Scans and Blood Work

Generally, scans (like CT scans, PET/CT scans, and bone scans) and blood work (like tumor markers) for breast cancer surveillance are not routinely performed after treatment ends in patients who have no symptoms and have undergone a normal physical exam and mammogram.

The American Society of Clinical Oncology does not recommend the routine use of scans or blood work for patients who do not have symptoms or abnormalities on clinical exam. These tests by themselves are often a poor indicator of breast cancer recurrence. They can be too sensitive (resulting in false positives); they may lead to additional unnecessary tests and biopsies; and they have not been shown to improve outcomes in patients with early stage breast cancer who develop a recurrence.

Currently, the only test recommended routinely is follow-up imaging of the treated breast, along with screening of the unaffected breast at least once a year.